1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novo Nordisk A/S
  6. News
  7. Summary
    NOVO B   DK0060534915

NOVO NORDISK A/S

(NOVO B)
  Report
Real-time Estimate Cboe Europe  -  03:36 2022-07-05 am EDT
795.05 DKK   -0.09%
07/04NOVO NORDISK A/S : Share repurchase programme
GL
06/30NOVO NORDISK A/S : The technical configuration is positive
06/29European ADRs Move Slightly Higher in Wednesday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

NOVO NORDISK : Berenberg remains Neutral

05/20/2022 | 05:45am EDT

Berenberg's research confirms his advice and maintains his neutral opinion on the stock. The target price is unchanged and still at DKK 780.


© MarketScreener with dpa-AFX Analyser 2022
All news about NOVO NORDISK A/S
07/04NOVO NORDISK A/S : Share repurchase programme
GL
06/29European ADRs Move Slightly Higher in Wednesday Trading
MT
06/28NOVO NORDISK : UBS lowers its rating to Sell
MD
06/27BNP Paribas Exane Upgrades Novo Nordisk to Neutral From Underperform
MT
06/27Novo Nordisk A/S – Share repurchase programme
GL
06/24NOVO NORDISK : UBS sticks Neutral
MD
06/24NOVO NORDISK : Goldman Sachs keeps its Buy rating
MD
06/23Camp Huronda welcomes back campers for a long-awaited reopening and unveils the new Ins..
AQ
06/22Novo Nordisk, Echosens Tie Up to Increase Early Diagnosis of Chronic Metabolic Liver Di..
MT
06/22Echosens and Novo Nordisk Announce Partnership to Increase Awareness and Advance Early ..
CI
More news
Analyst Recommendations on NOVO NORDISK A/S
More recommendations
Financials
Sales 2022 168 B 23 565 M 23 565 M
Net income 2022 53 555 M 7 508 M 7 508 M
Net cash 2022 1 888 M 265 M 265 M
P/E ratio 2022 33,7x
Yield 2022 1,45%
Capitalization 1 805 B 253 B 253 B
EV / Sales 2022 10,7x
EV / Sales 2023 9,40x
Nbr of Employees 49 295
Free-Float 69,6%
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 795,80 DKK
Average target price 813,00 DKK
Spread / Average Target 2,16%
EPS Revisions
Managers and Directors
Lars Fruergaard Jørgensen President & Chief Executive Officer
Karsten Munk Knudsen Chief Financial Officer & Executive Vice President
Helge Lund Chairman
Henrik Ehlers Wulff Senior Vice President-Diabetes API
Stephen Gough Global Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
NOVO NORDISK A/S8.27%253 094
JOHNSON & JOHNSON4.94%472 389
PFIZER, INC.-11.41%293 506
ELI LILLY AND COMPANY17.55%292 291
ROCHE HOLDING AG-14.90%274 360
ABBVIE INC.13.59%271 782